Go
MIR Research Laboratories

Find A Location

Search

Radiological Chemistry and Imaging Laboratory (RCIL)

Sally Schwarz

Contact Information
Washington University School of Medicine
Department of Radiology
Campus Box 8225
510 S. Kingshighway
St. Louis, MO 63110

Office:
1111 East Building
(314) 362-8426
schwarzs@mir.wustl.edu

Current Position
Professor of Radiology
Director, PET Radiopharmaceutical Production
Co-Director Cyclotron Facility in Radiology
 

Research Interests
My interest focuses on the regulatory issues involved in production and use of PET and SPECT radiopharmaceuticals in humans: Investigational New Drug Applications (INDs), Exploratory INDs, Expanded Access INDs and Radioactive Drug Research Applications.  These applications include preparation of Chemistry Manufacturing Control (CMC), dosimetry, and toxicology sections.  Additionally I have been involved in the design and installation of our Cyclotron Facility ISO Class 7 Nuclear Pharmacy.
 

Key Publications:

  1. Norenberg JP, Petry NA, Schwarz, SW Operation of a radiopharmacy for a clinical trial. Semin Nucl Med, 40:347-356, 2010.
  2. Decristoforo, C., Schwarz S W.; Radiopharmacy: Regulations and legislations in relation to human applications. Drug Discovery Today: Technologies doi:101016/j.ddtec.2011.11.012; 2011.
  3. Schwarz S, Norenberg J, Berridge M, Dragotakes S, Hung J, Link J, Mason NS, Mattmuller S, Nickel RA, Packard A, Paolino J, Petry N, Ponto J, Quinton TM, Seifert KL, Swanson D, Weiner RE, Zigler S. The future of USP Monographs for PET Drugs, J Nucl Med. 54(3):472-5, 2013..
  4. Cutler, CS, Schwarz SW. Diversification in the supply chain of 99Mo assures a future for 99mTc.  J Nucl Med. 22;55(7):1208-1213, 2014.
  5. Schwarz SW, Dick D, VanBrocklin HF, Hoffman JM. Regulatory requirements for PET drug production. J Nucl Med. 55(7):1132-1137, 2014.